04.03.17
Two more skin care manufacturers have been cited by the US Food and Drug Administration for making drug claims about their products.
In a Dec. 16, 2016 letter to Healthy Habits CEO Matthew Martin, FDA warned that the company’s website makes drug claims for DermaTox Ointment 1.7oz and DermaTox 4oz in both product descriptions, testimonials and Q&A.
More recently, in a Feb. 17, 2017 letter to Aegeia Skin Care Founder Rebecca Sue Wachsle, FDA charged that the company made drug claims for products including Purifying Facial Cleanser, Refining Facial Toner, Nourishing Clay Mask and Silken Body Butter. FDA took exception to claims such as “(s)timulating circulation.” for the facial cleanser; “Antibacterial & antimicrobial properties...” for the facial toner; “Dead Sea Clay...stimulating vital facial circulation.” for Nourishing Clay Mask.
In a Dec. 16, 2016 letter to Healthy Habits CEO Matthew Martin, FDA warned that the company’s website makes drug claims for DermaTox Ointment 1.7oz and DermaTox 4oz in both product descriptions, testimonials and Q&A.
More recently, in a Feb. 17, 2017 letter to Aegeia Skin Care Founder Rebecca Sue Wachsle, FDA charged that the company made drug claims for products including Purifying Facial Cleanser, Refining Facial Toner, Nourishing Clay Mask and Silken Body Butter. FDA took exception to claims such as “(s)timulating circulation.” for the facial cleanser; “Antibacterial & antimicrobial properties...” for the facial toner; “Dead Sea Clay...stimulating vital facial circulation.” for Nourishing Clay Mask.
